Antivirals
Social Evils
Hépatites virales C et B et infection par le VIH.pdf
Lessons learnt on Diaspora networks of the highly skilled Tanja Faller.
Clinical Trials on Trial The Patient Perspective Wim Vandevelde European AIDS Treatment Group (EATG) HAI Europe Open Seminar - November 21st 2008 - Berlin.
TB & HIV Infection: Treatment Your name Institution/organization Meeting Date International Standard 8, 13 TB & HIV Infection: Treatment Your name Institution/organization.
Living Science Abacavir Hypersensitivity - A model for Personalized Medicine Test Adoption Hawazin Faruki, DrPH VP, Clinical Development Laboratory Corporation.
Development of Pediatric ARV Drugs – FDA Perspective Linda L. Lewis, M.D. Medical Officer Division of Antiviral Drug Products U.S. Food and Drug Administration.
Immune System. First line of defense The skin serves as a physical barrier to prevent the passage of many disease-causing microorganisms. The skin is.
Seafarers and HIV infection Dr. Michaela Schuhwerk GUM Physician MRCP, DTMH, DipGUM, DFFP, MSc, CCST in GUM Medicine.
PAHO Forum on Bioethics, Public Health, and Health Policy PERSPECTIVES AND EXPERIENCES FROM JAMAICA Dr. Derrick Aarons MD, PhD Consultant Bioethicist
Miriam Lichtner Dipartimento di Malattie Infettive e Sanità Pubblica Sapienza Università di Roma Polo Pontino Componente dell Italian National Focal Point.